Find latest AML videos · 400+ videos
Roswell Park Comprehensive Cancer Center
S

Steroid-Refractory GVHD Updates

By Roswell Park Comprehensive Cancer Center FEATURING Shernan Holtan
By Roswell Park Comprehensive Cancer Center FEATURING Shernan Holtan
284 views
January 24, 2025
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Related Videos

International Congress on Cancer Metastasis

10th International Congress on Cancer Metastasis

Wed, Oct 29, 2025
45:42
Amgen Sponsorship

FDA Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey
25:03

ASH 2024 Summary: Highlights in AML, MDS, and ALL

2024 ASH Annual Meeting Insights Hub

T. Badar

1.8K views
23:28

Indy Hematology Review 2025: State of the Art 2025 - Emerging Therap…

Indy Hematology Review 2025

R. Birhiray

550 views
19:19

ASH 2024 Summary: Highlights in Adult ALL and Implications for Pract…

2024 ASH Annual Meeting Insights Hub

R. Cassaday

479 views
19:01

Debates in AML: 7+3 Is No Longer the Standard of Care

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

1.3K views
12:55

ASH 2024 Summary: Menin Inhibitors in AML - FDA Approval and Highlig…

2024 ASH Annual Meeting Insights Hub

J. Zeidner

540 views
16:32

Indy Hematology Review 2025: Experts Debate the Treatment of ALL in …

Indy Hematology Review 2025

H. Kantarjian

245 views
19:26

Indy Hematology Review 2025: Treatment Options for Newly Diagnosed A…

Indy Hematology Review 2025

D. Pollyea

214 views
21:24

ASH 2024 Insights: Venetoclax + Aza for 1L Younger AML Pts Independe…

2024 ASH Annual Meeting Insights Hub

J. Watts

411 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

5.1K views
15:16

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

2024 ASH Annual Meeting Insights Hub

H. Fernandez

311 views
33:46

ASH 2024 Review: Key Updates in Non-Hodgkin Lymphoma

Cleveland Clinic Taussig Cancer Institute

P. Caimi

282 views
17:10

What’s New in AML: Treatment Advances and Key Trials in 2024

OncoAlert

F. Haddad

142 views
27:04

ASH 2024 Treatment Updates in Lymphoma: Practice Changing and Promis…

UChicago Medicine

A. Rojek

224 views
16:57

ASCO® 2024 Summary: "Lymphoma Highlights"

2024 ASCO® Annual Meeting Insights Hub

B. D. Cheson

1.8K views
26:58

Understanding the AML Disease State: Key Challenges and Advances

Cleveland Clinic Taussig Cancer Institute

M. Mustafa Ali

168 views
16:16

ASH 2024 Summary: Highlights in Ph- ALL

2024 ASH Annual Meeting Insights Hub

F. Haddad

223 views
15:40

Indy Hematology Review 2025: Experts Debate the Treatment of ALL in …

Indy Hematology Review 2025

R. Stone

100 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

462 views
07:10

Long-Term Follow-Up of the VIALE-A Study: Survival Outcomes and Subg…

Walter Fiedler

166 views
AUTOPLAY